NYT NEW YORK TIMES CO Insider Trading

Levien sold 9,750 NYT shares at $78.00 on 2026-05-12; stock down -13.3% from 52-week high, down -6.5% in 30 days.

Levien Meredith A. Kopit, President & CEO of The New York Times Co, sold 9,750 shares at $78.00 for $760,500.00, reducing holdings from 219.6K shares to maintain a significant ownership position. The sale occurred as NYT stock is -13.3% from its 52-week high and down -6.5% over the past 30 days, suggesting the insider chose to exit during a period of price weakness. His cross-ticker track record shows modest sell-timing accuracy (14.29% well-timed rate across 8 prior sells with +2.5% avg 30d return), while his prior trades at NYT have yielded mixed results—only 1 of 5 prior sells were well-timed at the 90-day mark. The timing of this sale amid recent downward momentum and well below the 52-week high warrants monitoring for whether it signals CEO concerns or reflects routine portfolio management against a backdrop of elevated valuation (P/E of 35.78).

NYT CFO Bardeen William sold 13,000 shares ($1.0M) on 2026-03-03; post-sale holdings 18,681 shares (-41.0%).

Bardeen William, EVP and Chief Financial Officer of New York Times Co, executed a sale of 13,000 shares at $79.56 on 2026-03-03 for total value of $1,034,280.00, reducing his stake from 31,681 shares to 18,681 shares—a reduction of 41.0% versus pre-transaction holdings. At the time of sale, the stock was trading $2.39 below the current price of $81.95 and was up 13.5% over the prior 30 days and 26.6% over 90 days. The company's fundamentals show revenue of $700,821,000.00 in the latest quarter and net income of $81,647,000.00, with annual revenue growth of 9.2% and a P/E ratio of 38.84. The sale occurred while the stock was near its 52-week high of $81.95, reducing the CFO's direct equity exposure by a material amount.

NYT Chairman Arthur Sulzberger sold 13,000 shares at $79.95 on 2026-03-03, reducing stake to 172,338 shares.

Arthur G. Sulzberger, Chairman and Publisher of The New York Times Company, executed a sale of 13,000 shares for $1,039,348.70 total value, reducing his position by 7.0% from 185,338 to 172,338 shares. The company reported latest-quarter revenue of $700,821,000.00 and net income of $81,647,000.00, with annual revenue growth of +9.2%, indicating stable operational performance. As a major controlling shareholder and executive leadership, any change in Sulzberger's stake warrants monitoring, though a single discrete sale of this magnitude does not establish a directional pattern on its own. The transaction provides one data point in the company's insider activity landscape.

CEO Meredith Kopit Levien sold 51,949 shares of NYT at $79.70; holds 229,362 shares post-sale. Stock now $81.95.

KOPIT LEVIEN MEREDITH A. (PRESIDENT & CEO) sold 51,949 shares at $79.70 on 2026-03-03, reducing her NYT holdings by 18.5% from 281,311 to 229,362 shares. The current price of $81.95 is +0.0% from the 52-week high, indicating the stock remains near its peak. Her prior trades at NYT show a pattern of poor timing: 0 of 5 prior sells were well-timed (stock rose in the subsequent 90 days following all five prior sales), averaging +8.0% returns after those sells. The sale occurred at $79.70, below today's price, but occurred when the stock was near its 52-week high and amid strong recent momentum (+13.5% over 30 days, +26.6% over 90 days). Fundamentally, the company shows solid metrics with $700.8M quarterly revenue, +9.2% annual growth, and $81.6M net income, though the P/E of 38.84 reflects a premium valuation.

NYT President & CEO Kopit Levien sells 16,972 shares at $59.68; stock now at $62.59 (52-week high).

Kopit Levien sold 16,972 shares on 2025-11-06 at $59.68, reducing her stake by 13.8%. The sale occurred while the stock was 0.0% from its 52-week high of $62.59, and has since appreciated to that peak price, meaning the sale occurred near the top of the recent range. Across her 5 prior trades at NYT, none of the 90-day post-sale returns were negative (all showed positive returns, from +4.4% to +12.5%), indicating a consistent pattern of poorly-timed sales at this ticker. Her cross-ticker track record shows an average 90d return of +7.1% following sells with a well-timed rate of 0.00%, reflecting similar timing challenges across her broader open-market activity. The P/E of 34.97 and revenue growth of +6.6% reflect a relatively expensive valuation, though this transaction alone does not clarify her view on fundamental value versus near-term momentum.

NYT Chief Legal Officer Brayton Diane sold 10,000 shares for $564.8K, reducing holdings by 23.3% to 32,879 shares

Brayton Diane, serving as EVP and Chief Legal Officer, executed a sale of 10,000 shares at $56.48 on June 2, 2025, reducing her post-transaction holdings to 32,879 shares from 42,879 shares. The sale occurred near the 52-week high of $57.12, with the stock currently trading at $55.83 and having appreciated 17.9% over the prior 90 days. The transaction represents a substantial reduction (23.3%) in her direct holdings. With New York Times Co showing 6.6% annual revenue growth and a P/E of 31.19, the context includes solid near-term price momentum but a relatively elevated valuation multiple. The sale warrants disclosure review for any concurrent insider purchases or planned reacquisitions, and investors should monitor whether additional executive activity follows.

NYT CEO Meredith Kopit Levien sold 19,260 shares ($1.1M) on 2025-06-02, reducing holdings by 13.5% to 123,337 shares.

CEO Meredith Kopit Levien executed a $1.1M sale of 19,260 shares at $56.82, reducing her stake from 142.6K to 123.3K shares (a 13.5% reduction). The sale occurred near the 52-week high at -2.3% below peak, during a period of strong upward momentum: the stock advanced 6.8% over the prior 30 days and 17.9% over 90 days. Examining her NYT-specific selling history, all five prior sales at this ticker showed positive 90-day returns (ranging from +0.5% to +12.5%), indicating she has consistently sold before subsequent gains—a pattern of poorly-timed exits. Her cross-ticker track record similarly reflects muted timing discipline with a 0.00% well-timed rate across 5 prior sales. The company fundamentals remain solid with $635.9M in quarterly revenue, $49.6M net income, and 6.6% annual revenue growth, though a P/E of 31.19 reflects elevated valuation expectations.

NYT CEO Meredith A. Kopit Levien sold 19,869 shares at $50.53, reducing stake by 19.5% to 81,903 shares.

On 2025-02-13, Meredith A. Kopit Levien, President & CEO of New York Times Co., sold 19,869 shares at $50.53, reducing her holdings from 101,772 to 81,903 shares—a 19.5% reduction in her position. The stock now trades at $49.19, roughly -13.4% from its 52-week high of $56.83. Reviewing her same-ticker trade history at NYT, across four prior sells, zero were followed by declines within 90 days; instead, three of four generated positive 90-day returns (ranging from +0.5% to +12.5%), suggesting her prior sales have consistently missed subsequent rallies rather than avoiding downturns. Her cross-ticker track record shows an average 90-day return of +7.0% after prior sales with a well-timed rate of 0.00%, indicating a pattern of selling before appreciation rather than before declines. The current price decline of -5.2% over 30 days and -5.4% over 90 days represents a modest departure from her historical post-sale performance at this ticker, warranting observation to assess whether this sale marks a break in that pattern.

NYT CEO Meredith Kopit Levien sold 18,300 shares at $53.92; holds 101.8K shares post-sale.

KOPIT LEVIEN MEREDITH A., as President & CEO, sold 18,300 shares of NEW YORK TIMES CO for $986,772.60 on 2024-08-12, reducing her holdings from 120,072 to 101,772 shares (-15.2%). At current price of $54.56, the stock is -1.3% from its 52-week high of $55.29 and has climbed +13.8% over the past 90 days. Her same-ticker history shows 3 prior sales, none of which were well-timed at the 90-day mark; the most recent sale on 2024-05-10 saw the stock gain +12.5% in the subsequent 90 days, suggesting her prior sells did not precede material downturns. The company's fundamentals show Revenue of $625,097,000.00 and Net income of $65,540,000.00 in the latest quarter, with annual revenue growth of +5.1%, trading at a P/E of 38.70. The transaction occurs within a strong 90-day uptrend, and her cross-ticker selling track record shows a 0.00% well-timed rate, indicating her sales historically have not preceded declines.